Nextech Invest Ltd. located in Zurich, Switzerland, was founded in 1998 as an investment advisor and management company. Nextech Invest Ltd. has raised a total of USD 258 million in four investment funds and currently manages USD 174 million in three investment funds focused on oncology. Late 2006 saw the founding of Nextech II Oncology, the world's first globally active late-stage oncology fund; Nextech III Oncology, building on the success of its predecessor fund, followed in 2010. In 2014 Nextech IV Oncology was launched with a focus in companies developing cancer therapeutics.
We deploy our expertise in oncology to invest equity in companies developing cancer therapeutics led by outstanding management teams. Each investment is supported by an eminent group of seven experts in the field of oncology.
Your eMail have been successfully registered.Close